ICCM IceCure Medical Ltd.
IceCure Medical Ltd develops and markets minimally invasive cryoablation therapies for women's health and oncology markets. It offers ProSense system, a cryoablation solution for breast tumors. The company was founded in 2006 and is headquartered in Caesarea, Israel.
$1.35 -0.04 (-2.88%)
As of 01/26/2023 16:00:00 EST IEX book CBOE book
Security Information
Category1:
US EquityCategory2:
Common stocksCategory3:
Micro cap
GICS sector: Health Care
Industry: Medical Care Facilities
Index country: Israel
Country of incorporation:
IPO date: 02/09/2011
Outstanding shares: 45,623,434
Average volume: 780,704
Market cap: $58,854,230
Current dividend yield: 0.00%
All SEC filings:
SEC Edgar Online
Annual filings:
20-F
Sedol:
Valuation (See tab for details)
PE ratio: 0.00
PB ratio: 0.00
PS ratio: 0.00
Return on equity: 0.00%
Net income %: 0.00%